Renalis, Raises $824K to Advance its Digital Health Platform

Cleveland-based digital health company Renalis provides innovative digital therapy solutions to treat patients with pelvic health disorders. The company closed its $824K Pre-Seed funding round led by the Healthcare Collaboration Fund.

 

The Healthcare Collaboration Fund is managed through a partnership between Cleveland-based Venture Investor JumpStart Inc, and University Hospitals Ventures. "Renalis in tackling a significant unmet need in pelvic health management," said Hardik Desai, Sr. Investing Partner at JumpStart. "We are excited to partner with UH and Renalis to commercialize this important technology."


Renalis introduced digital therapy with its "CeCe" product. Its mobile application helps patients record and manage symptoms of Overactive Bladder (OAB). The funds will be used to intensify the research within University Hospitals, aid regulatory efforts and to build a diligent team to lead commercialization and technological advances.


The Healthcare Collaboration Fund is managed through a partnership between Cleveland-based Venture Investor JumpStart Inc, and University Hospitals Ventures. "Renalis in tackling a significant unmet need in pelvic health management," said Hardik Desai, Sr. Investing Partner at JumpStart. "We are excited to partner with UH and Renalis to commercialize this important technology."


"We are so grateful for this latest funding round," said Renalis CEO, Missy Lavender. "We can now accelerate our go-to-market plan to deliver evidence-based solutions to chronic, expensive, and prevalent conditions like OAB to millions of patients in the U.S. and beyond."